Free tool
FAERS Monitor: Pantoprazole Sodium In 0.9% Sodium Chloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 217512 or its brand name (Pantoprazole Sodium In 0.9% Sodium Chloride, Pantoprazole Sodium). Reports on generic versions are filed under their own applications.
Reports
63,382
Serious
51,028
81% of reports
Hospitalization
29,001
Death reported
7,825
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue7,509
- off label use6,452
- dyspnoea6,186
- pain6,112
- drug ineffective5,859
- diarrhoea5,757
- nausea5,700
- headache5,314
- arthralgia4,977
- pyrexia4,872
- rash4,405
- vomiting4,179
- pruritus3,862
- pneumonia3,765
- asthenia3,754
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 195 |
| 2005 | 655 |
| 2006 | 888 |
| 2007 | 965 |
| 2008 | 1,224 |
| 2009 | 1,189 |
| 2010 | 664 |
| 2011 | 794 |
| 2012 | 759 |
| 2013 | 348 |
| 2014 | 472 |
| 2015 | 1,589 |
| 2016 | 1,762 |
| 2017 | 1,808 |
| 2018 | 2,570 |
| 2019 | 2,988 |
| 2020 | 3,530 |
| 2021 | 5,120 |
| 2022 | 8,294 |
| 2023 | 6,925 |
| 2024 | 8,232 |
| 2025 | 7,486 |
| 2026 | 4,924 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,990,777 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pyrexiaSignal | 4,872 | 4.7 | 4.6 | 14,337 |
| arthralgiaSignal | 4,977 | 4.0 | 3.9 | 11,323 |
| pneumoniaSignal | 3,765 | 3.9 | 3.8 | 8,121 |
| dyspnoeaSignal | 6,186 | 3.7 | 3.6 | 12,125 |
| rashSignal | 4,405 | 3.4 | 3.3 | 7,450 |
| pruritusSignal | 3,862 | 3.4 | 3.3 | 6,448 |
| astheniaSignal | 3,754 | 3.3 | 3.2 | 6,189 |
| painSignal | 6,112 | 3.3 | 3.2 | 10,131 |
| fatigueSignal | 7,509 | 3.2 | 3.2 | 11,831 |
| diarrhoeaSignal | 5,757 | 3.0 | 2.9 | 7,727 |
| vomitingSignal | 4,179 | 3.0 | 2.9 | 5,523 |
| headacheSignal | 5,314 | 2.8 | 2.8 | 6,416 |
| off label useSignal | 6,452 | 2.5 | 2.4 | 5,766 |
| nauseaSignal | 5,700 | 2.4 | 2.3 | 4,801 |
| drug ineffective | 5,859 | 1.5 | 1.4 | 959 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.